Protara Therapeutics, Inc. TARA

Things are moving in the right direction, when this stock is traded at 26-30$ who will care that it was dirt cheap today. $TARA

$TARA Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Protara Therapeutics
October 15, 2026 08:00 ET

Little shaking and they be running lol

$TARA those who are afraid to lose don’t deserve win. Once they get FDA approval they will reach analyst target price and it will just be the beginning of something bigger.

I am on board till the end whether it goes to 0 or I will become a hero. As per the test results things are fine, Bank of America loaded up on $TARA, something is happening, could be happening, shorts closing thier positions or a dump before a huge pump/news.

1. THRIVE-3 Trial Interim Results (Estimated Window: November – December 2026)
   • The Milestone: This is the most crucial near-term "success or failure" binary event. The registrational Phase 3 trial is testing IV Choline Chloride for patients dependent on long-term intravenous nutrition.
   • What Success Looks Like: Positive interim data from this study will mathematically validate the drug's efficacy and safety profiles, directly smoothing the path toward regulatory approval.
2. STARBORN-1 Pivotal Trial Update (Estimated Window: November – December 2026)
   • The Milestone: Full enrollment completion and a comprehensive data update from the STARBORN-1 trial evaluating their lead asset, TARA-002, in pediatric lymphatic malformations.
   • What Success Looks Like: Strong efficacy and durability metrics here are critical because the company is actively preparing this exact dataset to support their Biologics License Application (BLA) submission to the FDA

Idiots, put stop loss on future profits, wait till December, that’s when things should start moving.

When it skyrockets institutions/smart money will love it at 20-26$. $TARA our time will come.

$TARA it’s coming eventually, so many analysts can’t be wrong, just a question of time, when it becomes really parabolical it’s going to be beautiful to watch.

‏Bank of America Corp DE Buys 430,014 Shares of Protara Therapeutics, Inc. $TARA
‏Defense World StaffAug 29th, 2026

TARA — catalyst calendar
Period What to watch My expected stock impact
Aug–Sep 2026 ADVANCED-3 redesign / trial details 🟡 10–25% possible
Sep–Oct 2026 Further TARA-002 bladder-cancer updates 🟠 15–40% possible
Oct–Dec 2026 ADVANCED-2 completes BCG-unresponsive enrollment 🟠/🔴 Important
Q4 2026 THRIVE-3 interim Phase 3 results 🔴 Biggest near-term binary catalyst
Q4 2026 STARBORN-1 completes enrollment + additional LM data 🔴 Potentially major
Early 2027 More TARA-002 efficacy/durability data 🔴 Potentially major
2H 2027 TARA-002 BLA submission for lymphatic malformations 🔴🔴 Major
2027–28 Potential FDA approval/commercialization